Soluble factor(s) released from neutrophils activates endothelial cell matrix metalloproteinase-2

Journal of Surgical Research

Volumn 76, Issue 1, 1998, Pages 79-85

  Schwartz, Jess D ^a   Monea, Sara ^a   Marcus, Stuart G ^a   Patel, Sundeep ^a   Eng, Kenneth ^a   Galloway, Aubrey C ^a   Mignatti, Paolo ^a   Shamamian, Peter ^a  

^a NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Matrix metalloproteinases; MMP 2; Neutrophils; Proteolytic activation

Indexed keywords

1,10 PHENANTHROLINE; ACID PROTEINASE; APROTININ; BATIMASTAT; COLLAGEN TYPE 4; CYSTEINE PROTEINASE; EGLIN C; FIBRONECTIN; GELATIN; GELATINASE A; N [N (3 CARBOXYOXIRANE 2 CARBONYL)LEUCYL]AGMATINE; PEPSTATIN; PLASMIN; POLYCARBONATE;

CELL INTERACTION; CONFERENCE PAPER; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; MULTIPLE ORGAN FAILURE; NEUTROPHIL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; UMBILICAL VEIN; VASCULAR ENDOTHELIUM;

EID: 0031880691     PISSN: 00224804     EISSN: None     Source Type: Journal    
DOI: 10.1006/jsre.1998.5294     Document Type: Conference Paper

References (27)

1. Beal A. L., Cerra F. B. Multiple organ failure syndrome in the 1990s: Systemic inflammatory response and organ dysfunction. J. Am. Med. Assoc. 271:1994;226.
2. Weiss S. J. Tissue destruction by neutrophils. N. Engl. J. Med. 300:1988;365.
3. Gay J. C. Priming of neutrophil oxidative responses by platelet-activating factor. J. Lipid Mediat. 2:1990;S161.
4. Botha A. J., Moore F. A., Moore E. E., Kim F. J., Banerjee A., Peterson V. M. Postinjury neutrophil priming and activation: An early vulnerable window. Surgery. 118:1995;358.
5. Liotta L. A., Steeg P. S., Stetler-Stevenson W. G. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation. Cell. 64:1991;327.
6. Mignatti P., Rifkin D. B. Biology and biochemistry of proteinases in tumor invasion. Physiol. Rev. 73:1993;161.
7. Kleiner D. E., Stetler-Stevenson W. G. Structural biochemistry and activation of matrix metalloproteinases. Curr. Opin. Cell Biol. 5:1993;891.
8. Matrisian L. M. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet. 6:1990;121.
9. Senior R. M., Griffin G. L., Fliszar C. J., Shapiro S. D., Goldberg G. I., Welgus H. G. Human 92- and 72-kilodalton type IV collagenases are elastases. J. Biol. Chem. 266:1991;7870.
10. Aimes R. T., Quigley J. P. Matrix metalloproteinase-2 is an interstitial collagenase. J. Biol. Chem. 270:1995;5872.
11. Unemori E., Bouhana K. S., Werb Z. Vectorial secretion of extracellular matrix proteins, matrix-degrading proteinases, and tissue inhibitor of metalloproteinases by endothelial cells. J. Biol. Chem. 265:1990;445.
12. Stetler-Stevenson, W. G. Progelatinase A activation during tumor cell invasion, Invasion Metast. 14, 1, 6.
13. Gilles C., Polette M., Piette J., Munaut C., Thompson E. W., Birembaut P., Foidart J. M. High level of MT-MMP expression is associated with invasiveness of cervical cancer cells. Int. J. Cancer. 65:1996;209.
14. Mazzieri R., Masiero L., Zanetta L., Monea S., Onisto M., Garbisa S., Mignatti P. Control of type IV collagenase activity by components of the urokinase-plasmin system: A regulatory mechanism with cell-bound reactants. EMBO J. 16:1997;2319.
15. Kolev K., Komorowicz E., Owen W. G., Machovich R. Quantitative comparison of fibrin degradation with plasmin, miniplasmin, neurophil leukocyte elastase and cathepsin G. Thromb Haemost. 75:1996;140.
16. Boyum A., Lovvhaug D., Tresland L., Nordlie E. M. Separation of leucocytes: Improved cell purity by fine adjustments of gradient medium density and osmolality. Scand. J. Immunol. 34:1991;697.
17. Bahou W. F., Coller B. S., Potter C. L., Norton K. J., Kutok J. L., Goligorsky M. S. J. Clin. Invest. 91:1993;1405.
18. Collier I. E., Wilhelm S. M., Eisen A. Z., Marmer B. L., Grant G. A., Selzer J. L., Kronberger A., He C., Bauer E. A., Goldberg G. I. H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloproteinase capable of degrading basement membrane collagen. J. Biol. Chem. 263:1988;6579.
19. Goldberg G. I., Collier I. E., Eisen A. Z., Grant G. A., Marmer B. L., Wilhelm S. M. Mosaic structure of the secreted ECM metalloproteases and interaction of the type IV collagenases with inhibitors. Matrix Suppl. 1:1992;25.
20. Kjeldsen L., Bainton D. F., Sengelov H., Borregaard N. Identification of neutrophil gelatinase-associated lipocalin as a novel matrix protein of specific granules in human neutrophils. Blood. 83:1994;799.
21. Murphy G., Cockett M. I., Stephens P. E., Smith B. J., Docherty A. J. P. Stromelysin is an activator for pro-gelatinase. Biochem. J. 248:1987;265.
22. Atkinson S. J., Crabbe T., Cowell S., Ward R. V., Butler M. J., Sato H., Seiki M., Reynolds J. J., Murphy G. Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes. J. Biol. Chem. 270:1995;30479.
23. Strongin A. Y., Collier I., Bannikov G., Marmer B. L., Grant G. A., Goldberg G. I. Mechanism of cell surface activation of 72-kDa type IV collagenase. J. Biol. Chem. 270:1995;5331.
24. Will H., Atkinsons S. J., Butler G., Smith B., Murphy G. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of the progelatinase A and initiates autoproteolytic activation. J. Biol. Chem. 271:1996;17119.
25. Sato H., Takino T., Kinoshita T., Imai K., Okada Y., Stetler-Stevenson W. G., Seiki M. Cell surface binding and activation of gelatinase A induced by expression of membrane-type-1-matrix metalloproteinase (MT1-MMP). FEBS Lett. 385:1996;238.
26. Strongin A. Y., Marmer B. L., Grant G. A., Goldberg G. I. Plasma membrane dependent activation of the 72-kDa type IV collagenase is prevented by complex formation with TIMP-2. J. Biol. Chem. 268:1993;14033.
27. Monea, S. Lehti, K. Keski-Oja, J. Mignatti, P. Cooperation between plasmin and membrane-type 1 matrix metalloproteinase (MT1-MMP) in the cell surface activation of gelatinase A (MMP-2).